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ABSTRACT
PURPOSE This study was designed to determine whether the use of advanced features of
an electronic medical record in a primary care setting could improve the process of
delivering diabetes care in such a way as to produce improvements in diabetic outcome
measures in adult type II diabetic patients.
METHODS The study was a Retrospective Cohort Study conducted in primary care clinics
that had an established electronic medical record following 307 adult patients with type II
diabetes over the course of two years. The clinics had similarly trained primary care
physicians, similar patient populations, and used common diabetic care guidelines. The
advanced EMR features used during the diabetic study included a diabetic template,
premade laboratory requisitions, appeared consultations, flow sheets, and patient alerts.
The dependent variables measured included the process of the delivery of diabetic care and
the measurement of diabetic outcomes. The process of care measures were: the frequency
of visits specific for diabetes care, ordering of HbA1c and LDL cholesterol, the
measurement of blood pressure, and the documentation of these activities. The outcome
measures included glycemic, lipid and blood pressure control as measured by HbA1c, LDL
and blood pressure levels. The two independent variables of interest in the study were the
extent to which the advanced features EMR are use by the physician and the second any
changes noted in the outcome measures.
RESULTS The demographic information for the patients in this study was sex and age as
well as baseline HbA1c, LDL, baseline systolic blood pressures, baseline diastolic blood
pressures, and the number of visits that each patient had during the study period. The two
groups were seen to be similar at baseline except for age and systolic blood pressure. The
mean age of the intervention group was four years older than the control group and the
comparison group had more people with systolic blood pressure at target. Age and systolic
blood pressure were therefore controlled in the analysis. There was no difference in the
two groups of patients in terms of measurements of HbA1c but there were differences in
the frequency of measurements of LDL and blood pressures. Patients for whom the
template was used during at least one clinical encounter, were 1.18 times more likely to
have their LDL measured and 1.9 times more likely to have their blood pressure measured.
Using logistics regression analysis there was a higher proportion of patients with an LDL at
target in the intervention group.
CONCLUSIONS The meaningful use of EMRs in primary care, is possible through a process
of maturity by design; an individualized approach looking at the needs of a given
physician(s) and their practice(s) most likely to aid EMRs in achieving their potential. The
technology needs to support care by automation of clinical processes and work flow behind
the computer screen in such a way as to not disrupt or significantly change the patient
physician interaction and focus both of these individuals on managing meaningful clinical
outcomes personalized to each patient.
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CHAPTER 1: Introduction
1.0 Overview of the chapter
Electronic medical records are computer-based patient records detailing patient
demographics, medical and drug history, and diagnostic and laboratory information. They
are described as being transformative in nature, with the potential to fundamentally
change the work, productivity and processes in community-based practices thereby
facilitating enhanced delivery of care. Chronic disease in general, and diabetes in particular
present an ideal opportunity for the incorporation of health information technology into
the provision of primary care medicine. The disease is highly prevalent in primary care
populations, especially in Newfoundland and Labrador, is frequently associated with
comorbid conditions, and requires multiple medications in its management. Additionally
the effective care of a diabetic patient involves monitoring of several measures of disease
control such as HbA1c and low-density lipoprotein levels as well as blood pressures. All of
these factors combined to make diabetes an opportune disease state for the study of the
implementation of health information technology in the management chronic disease
conditions.

1.1 Introduction to the topic
Diabetes mellitus is a disease condition characterized by a disruption in glucose hemostasis
that affects approximately 23 million people in Canada and the United States and accounts
for approximately 105 billion dollars in annual health care costs.1 Diabetic patients belong
to one of two different disease classifications depending upon the underlying pathology.
Type 1 diabetes, characterized by an absolute insulin deficiency, results from the
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autoimmune destruction of the insulin-producing pancreatic beta cells, while Type 2
diabetes, results from in a relative deficiency in insulin due to both impaired insulin
secretion and resistance to its action, often secondary to obesity. Ninety to ninety-five
percent of patients with diabetes have type 2 diabetes. In addition to being a major risk
factor for cardiovascular disease, diabetes is also the primary cause of renal failure,
blindness and non-traumatic limb amputation worldwide.2 This is in spite of the
availability of affordable and well-tolerated medications and the presence of evidence
based clinical guidelines on the management of the disease.

Attempts to disseminate clinical practice guidelines (CPGs) for the management of diabetes
have increased markedly in the past twenty years.3 The motivation for this is the belief that
CPGs can improve the quality of care by: increasing the use of evidence-based therapeutics
to achieve identified targets; reducing harmful management strategies; and improving cost
effectiveness. 4In spite of the wide spread dissemination, research suggests the guidelines
are not as widely adopted as their authors might have wished.5 Cabana et al.6 attempted to
determine why this is the case and reviewed 76 papers that investigated barriers to
physician use of CPGs. The authors identified 293 individual barriers, which they
subsequently divided into three broad groups: Physician knowledge, defined as a lack of
awareness of and familiarity with the CPGs; Physician attitudes, which included a lack of
agreement on specific guidelines, concern about whether the guidelines would work in
actual patient populations, and skepticism about implementing GPGs into their practice;
and Factors external to the physician, relating to the difficulty or complexity of the
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guidelines, and a lack of resources for the implementation of the recommendations into
their practices.

The majority of care for diabetics is provided in the community primary care practice
setting. An environment characterized by short visits, competing visit objectives, issues
around the management of multiple patient morbidities and medications, and patient and
physician inertia related to the management of chronic disease conditions, it suffers also
from an inadequate information structure.7

These are significant barriers to the management of diabetes, which are even more
pronounced if an innovative approach to diabetes is applied to the management of the
condition. In such an innovative paradigm the patient is not a passive recipient of medical
ministrations but rather a part of a unit with the main provider serving as a resource coach
and the patient as the principal driver of change. Regardless of which approach is taken in
the treatment of type 2 diabetes information management is critical.
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1.2 Literature on the effectiveness and impact of EMRs on Diabetes

1.2.1 Introduction
A literature review was conducted according to the methods provided by the Preferred
Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) 2009 flow diagram.8

1.2.2 Background
Electronic medical records (EMRs) have been proposed as an effective health information
management tool to improve diabetes care.9 Proponents suggest the EMR can be used to
identify patients with diabetes, assess if the patient is due any tests or screening
procedures, and populate flow sheets used to track goals for glycemic, lipid and blood
pressure control. Furthermore, EMRs have also been advanced as a means to improve the
coordination of care among members of the health care team,10 decrease the instance of
incomplete clinical data,11 and support evidence based clinical decision-making.12
Movement towards wide-spread adoption of EMRs has been relatively slow with the 2013
National Physician Survey (NPS) showing exclusive use of EMRs by family physicians and
general physicians at 64.3% and other specialists across Canada at 59.5%. Further
research showed that 20 percent of users were only using basic EMR features such as
patient data and prescribing13 and only 4 to 6 percent of clinicians were utilizing full
functionality for results management and clinical decision support.14 15

Multiple uncontrolled studies have shown improvement in diabetes care temporally linked
to EMR use, which may be over-stated given the general improvement in diabetes care over
the past decade.16 Controlled studies show limited positive impact on out-patient diabetes
4|Page

care17 with the principle improvement being in processes of diabetic care. Commercially
developed EMRs do not seem to improve patient care in the primary care setting18 while
systems developed in-house over time improve adherence to clinical guidelines.19 The
research objective of this thesis is to determine if an EMR, configured with a locally
developed diabetes profile and supported with clinical decision making tools, improves the
management of patients as measured in terms of achieving three primary targets: blood
pressure; HbA1c; and low density lipoprotein. The study is a before and after trial in which
each physician’s management of their diabetic patients is evaluated prior to and after the
implementation of enhanced EMR features. The study involves seven family physicians in
two clinics caring for over seven hundred diabetic patients.
1.2.3 Literature Search Strategy
A search strategy was formulated to answer the clinical question of the impact of an EMR
on the management of adult patients with type-two diabetes by family physicians in a
primary care setting. Particular attention was paid to randomized controlled trials, as
these were most likely to provide valid information on the extent of the impact of the
electronic interventions on the management of diabetes. Studies addressing the research
question were identified through an electronic search of Pubmed/Medline, Embase, and
Cinahl databases. The databases were searched by using a combination of databasespecific subject headings (starting from the following Mesh Terms: computer or electronic
or EMR and diabetes or diabetic and primary care or family medicine or family practice or
therapy computer-assisted or electronic health records and diabetes, type /organization
and administration or diabetes, type 2/prevention and control or diabetes, type
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2/rehabilitation or diabetes mellitus, type 2/therapy and primary health care or family
practice) and text-words for each domain in the search field.

Furthermore the search was expanded to include hand searches of the references related of
the most relevant articles and the 2013 Diabetes Clinical Practice Guidelines.

The search was limited to English language publications from the last ten years and
inclusion restricted to studies that described primary care physicians’ use of electronic
medical records in community practices to manage adult type 2 diabetic patients. The
included studies looked at review articles, papers reporting on outcome measures and,
research focused on both process and outcome measures.

1.2.4 Exclusion and Sorting
Papers were excluded if they did not describe the management of adult type 2 patients in
primary care practices with electronic medical records. The initial screening was done by
the author reviewing titles and abstracts and then examining the full-text versions of
selected articles to further assess relevance of the research topic.

1.2.5 Findings
A total of three hundred and forty three studies were identified and the search strategy
used to identify the relevant articles is depicted in figure form (Figure 1). A summary of
the relevant articles is presents in table form. (Tables 1-3).
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Identification

Figure 1: PRISMA 2009 Flow Diagram

Records identified through
database searching
(n = 343)

Additional records identified
through other sources
(n = 8)

Eligibility

Screening

Records after duplicates removed
(n = 313)

Records screened
(n = 313)

Records excluded
(n = 283)

Full-text articles assessed
for eligibility
(n = 30)

Full-text articles excluded,
with reasons
(n = 21)

Included

Studies included in
qualitative synthesis
(n = 9)

Studies included in
quantitative synthesis
(meta-analysis)
(n = 9)
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Table 1: Summary of Relevant Review Articles
Title, Author, and Year
A Proposal for Electronic
Medical Records in U.S
Primary Care. Bates (2003)

Type of Paper
Position paper developed over four
years by multiple organizations
representing 300,000 primary care
practitioners in the United States.

Information Technology for
Clinical Guideline
Implementation: Perceptions
of Multidisciplinary
Stakeholders. Lyons (2004)

Descriptive content analysis of
1,500 pages of focus group
transcripts.

Information Technology for
the Treatment of Diabetes:
Improving Outcomes and
Controlling Costs. Wyne
(2008)

Review article examining the
practical applications of HIT for
improving the delivery of care in
diabetics

The use of information
technology to enhance
diabetes management in
primary care: a literature
review. Adaji (2008)
How to Successfully Select and
Implement Electronic Health
Records in Small Ambulatory
Practice Settings. Lorenzi
(2009)

A literature review

Use of Health Information
Technology to Advance
Evidence-Based Care: Lessons
from VA QUERI Program.
Hynes (2009)

Document analysis of 86
implementation project abstracts
followed up by semi-structured
interviews with key informants
from nine centres evaluated with
qualitative and descriptive analysis.
Review of literature examining the
role that clinical workflow plays on
the successful implementation of
HER in ambulatory care settings

Health Information
Technology: Integration of
Clinical Workflow into
Meaningful Use of Electronic
Health records. Bowens
(2010)
Electronic Health Records and
Quality of Diabetes Care.
Cebul (2011)

Review paper providing an
overview from the literature of the
perceived benefits and barriers to
adopting HER into smaller
practices.

Retrospective cohort of primary
care practices of seven diverse
health care organizations that
publically reported achievement of
quality standards for adults with

Conclusions
Electronic medical records provide many
benefits, especially to primary care providers
and given that such benefits are population
wide they should be funded with
public-private partnerships.
Administrators, physicians, and nurses hold
different opinions about specific facilitators
and barriers to information technology and
clinical guideline use. Such disparate
perceptions could undermine guideline
initiatives.
Implementation of information technology
enabled diabetes management has
demonstrated significant potential for
improving processes of care, preventing
development of diabetic complications, and
generating cost savings. It improves the
synthesis of information, the delivery of
knowledge, and the efficacy of
communication, allowing for coordination
of care across teams. The diabetes
registries show the most potential benefit
for improving outcomes and reducing costs.
Information technology can be used to
improve diabetes care by promoting a
productive and informative interaction
between the patient and the care team.
The EMR implementation experience
depends upon a variety of factors including
the technology, training, leadership, the
change management process, and the
individual character of each ambulatory
practice environment. Sound processes
must support both technical and personnelrelated organizational components.
Collaboration with multiple stakeholders is
a key factor in successful use and
development of HIT in implementation
research efforts and in advancing evidencebases practice.
The integration of EMR into clinical
workflow will require a synergy between
multiple approaches.

Federal Policies encouraging the
meaningful use of EHRs may improve the
quality of diabetes care across insurance
types.
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Qualitative Evaluation of a
Diabetes Electronic Decision
Support Tool: Views of Users.
Wan (2012)

diabetes between July 2007 and
June 2010.
Qualitative study of telephone
interviews of practitioners who had
used an EDS tool for a minimum of
six weeks. The transcripts were
coded and thematically analyses
using NVivo software.

The EDS tool showed promise as a way of
summarizing information about patients’
diabetes state, as a reminder of required
diabetes care and an aide to patient
education.

According to Wyne (2008), diabetes management enabled by health information technology has
a significant potential for improving the process by which such care is delivered, thereby
preventing the development of diabetic complications and generating system wide cost savings.
In the literature review conducted by Adaji (2008), it was noted that information technology can
improve productivity, and information interaction between the patient and the care team, but
different opinions about specific facilitators and barriers to information technology adaption
(identified by Lyons) among administrators, physicians, and nurses, suggests that this process
may be problematic as a lack of collaboration between multiple stakeholders may lead to an
unsuccessful HIT implementation. The success of an EMR implementation is dependent upon: the
nature of the technology itself; the quality of training; the leadership within the group; the
change management process; and the individual character of the practice in which the
implementation is being undertaken (Lorenzi). Integrating the electronic medical record into the
clinical workflow rather than structuring the delivery of care to fit the EMR is key to a successful
implementation (Bowens) and tools that summarize information about an individual patient's
diabetic state and remind the clinician of the requirement for diabetic care show promise in the
management of these patients.
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Table 2: Summary of Relevant Outcome Articles
Title, Author, and Year
The Impact of Planned Care
and a Diabetic Electronic
Management System on
Community-Based Diabetes
Care. Montori (2002)

Type of Paper
Before and after study comparing
metabolic outcomes (including
HbA1c, lipids and blood pressure
values) over a twenty-four-month
period in adult type two diabetics.
Two hundred randomly selected
patients were followed and a
multivariable analysis used to
estimate the association between
planned care and a diabetes
electronic management system.

Conclusions
Planned care was associated with improved
performance and metabolic outcomes in
diabetics in the primary care setting.

Table 3: Summary of the Process and Outcome Article
Title, Author, and Year
Linking Guidelines to
Electronic Health Records
Design for Improved Chronic
Disease Management.
Barretto (2003)

Type of Paper
A case study of guideline-compliant
treatment of hypertension in
diabetes with reference to the
guideline algorithm from the Texas
Diabetic Council

Impact of an Electronic
Medical record on Diabetes
Quality of Care. O’Connor
(2005)
Electronic Medical records
and Diabetes Quality of Care:
Results from a sample of
Family Medicine Practices.
Crosson (2007)

Five year longitudinal study of 122
adult type two diabetics in an EMR
clinic and a non-EMR clinic.

Electronic Medical recordsAssisted Design of a ClusterRandomized Trial to Improve
Diabetes Care and Outcomes.
Love (2007)
Improving Diabetes Care in
Practice Findings from the
TRANSLATE Trial. Peterson
(2008)

Individualized Electronic

Cross-sectional analysis of baseline
data from 50 practices participating
in a practice improvement study
between April 2003 and December
2004. A chart audit review a
random sample of medical records
for adherence to guidelines for
diabetic processes of care,
treatment, and achievement of
intermediate outcomes.
Clustered randomized trial of
12,675 patients comparing the
effect of an EMR-facilitated disease
management system against patient
empowerment.
A group-randomized controlled
clinical trial evaluating the practical
effectiveness of a multicomponent
intervention in 24 practices. The
intervention included
implementation of an electronic
diabetic registry, visit reminders,
and patient-specific physician
alerts.
A pragmatic randomized trial

Conclusions
In the operation of an electronic chronic
disease management system the
information sourced from a common
guideline must coordinate with the EMR
content and should provide clear
documentation of the clinical decisions
taken.
The EMR lead to an increased number of
HbA1c and LDL tests but not to improved
metabolic control.
The use of an EMR in primary care
practices is insufficient for insuring highquality diabetes care. Effort to expand EMR
use should focus not only on improving
technology but also on developing methods
for implementing and integrating this
technology into practice reality.

EMRs facilitated rigorous CRT design
enables fair comparisons and can be
replicated for other conditions enhancing
the power of translational investigations.
Introduction of a multicomponent
organizational intervention in the primary
care setting significantly increases the
percentage of type two diabetic patients
achieving the recommended clinical
outcomes.

A shared electronic decision-support
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Decisions support and
Reminders to Improve
Diabetes Care in the
Community: COMPLETE II
Randomized Trial
Beyond Health Information
Technology: Critical Factors
Necessary for Effective
Diabetes Disease
Management. Ciemins (2009)

involving adult type two diabetics
who are assigned to regular care or
an intervention wing with a web
based color-coded diabetes tracker.

system to support the primary care of
diabetes improves the process of care and
some clinical markers of the quality of
diabetes care.

A pre/post intervention cohort
analysis of 495 adult patients
selected randomly and followed for
six years. Two intervention phases
were followed the first consisted of
education and the second an EHR
diabetes management period which
included a diabetes registry and
office workflow changes.

Implementation of a specialized EMR
combined with tailored office workflow
process changes was associated with
increased adherence to ADA guidelines.

Impact of Electronic Health
Record Clinical Decision
Support on Diabetes Care: A
Randomized Trial. O’Connor
(2011)

A clinical-randomized trial
conducted from October 2006 to
May 2007 of 2,556 patients in 11
clinics and 41 primary care
physicians. Patients were
randomized to either receive or
not receive an EHR based clinical
decision support system to
improve care for patients whose
biochemical markers were not at
target during any office visit.
Group-randomized quality
improvement trial with 798
patients, which used hierarchical
linear models to examine the
relationship between EHR use
adherence to evidence-based
diabetes, care guidelines, and
hierarchical logistic models to
compare rates of improvement over
three years.

EHR-based diabetes clinical decisions
support significantly improved glucose
control and some aspects of blood
pressure control in adults with type two
diabetes.

Typical Electronic Health
Record Use in Primary Care
Practices and the Quality of
Diabetes Care. Crosson
(2012)

Consistent use of an EHR over three years
does not ensure successful use for
improving the quality of diabetes care.

The use of an EMR in primary care practices even over a significant period of time is insufficient
on its own to ensure high-quality diabetic care (Crosson) and may simply lead to the ordering of
an increased number of hemoglobin A-1C and LDL tests with no measurable improvement in
metabolic control (O’Connor). Increased adherence with the diabetic guidelines are seen when
fully functional and specialized EMRs are combined with office workflow process changes
(Ciemins) and multicomponent organizational intervention in primary care clinics increase the
percentage of type II diabetic patients at the recommended clinical outcomes (Peterson).
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1.3 Literature on Health Information Technology (HIT) in the Management of Adult Type Two
Diabetics by Family Physicians in Primary Care

1.3.1 What is HIT
Over the last twenty years primary care has been advanced as both an orientating philosophy for
the provision of community based medical services and as an actionable strategy for promoting
and protecting the health of individuals in a cost effective manner. A study performed by
Macinko and colleagues, which examined the impact of primary care systems in eighteen OECD
countries from 1970-1998, demonstrated that nations with strong primary care systems had
lower all-cause mortality, lower all-cause premature mortality and, lower all-cause mortality
from selected chronic diseases.20 In the United States of America the supply of primary care
physicians has been showed to be associated with better health outcomes which include: lower
all-cause mortality21; lower rates of cancer, heart disease and infant mortality22; and longer life
expectancy23. The United Kingdom showed higher numbers of primary care physicians are
associated with better self-reported health24 and less obesity25. While Canadian studies have
demonstrated how a larger supply of family physicians has been associated with earlier detection
of breast cancer26, more recommended newborn and preventive care visits for children,27 and
improved population health outcomes at a provincial level.28

Primary care was defined by the American Institute for Medicine in the late nineties as, “the
provision of integrated, accessible health care services by clinicians accountable for addressing
most personal health care needs, as developing a sustained partnership with patients, and
practicing in the context of family and community.”29 This mirrored the definition advanced by
Barbara Starfield that primary care is “that level of a health care service system that provides
entry into the system for all new needs and problems, provides person-focused (not disease12 | P a g e

orientated) care over time, provides care for all but very uncommon or unusual conditions, and
co-ordinates or integrates care provided elsewhere by others”.30 The Canadian Institutes for
Health Research (CIHR) has championed the term “community-based primary health care”
(CBPHC) as a “ broad range of primary prevention and primary care services within the
community, including health promotion and disease prevention; the diagnosis, treatment and
management of chronic and episodic illness; rehabilitation support; and end of life care.”31
From 2000 to 2006 the province of Newfoundland and Labrador received 9.7 million dollars
from the Federal government to aid in primary health care renewal. Funding was used, in part, to
create networks of nine primary health care teams in order to provide a continuum of services
including the treatment and management of chronic diseases. With the end of Federal funding in
2006, and the province’s decision not to continue funding, the office of Primary Health Care
closed. According to a report from the Auditor General of Newfoundland and Labrador, “As a
result (of the closure of the office of Primary Health Care) the Province has not progressed to the
level at which it should be with regard to the management and control of chronic disease.”32 The
report continues to state that the elimination of the office resulted meant that the Department of
Health was no longer providing support for the diabetes visits flow sheet to primary care
providers and that funding for the Provincial Chronic Disease Collaborative Database which
collected and reported the data contained in these sheets also ceased. According to the auditor
this means that the Canadian Diabetes Association’s estimates of the burden of diabetes in
Newfoundland and Labrador has not captured the true cost of the condition due to incomplete
data. (Table 4).
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Table 4: The Burden of Diabetes in Newfoundland and Labrador
Key Statistics
Estimated diabetes
prevalence (%)
Estimated number of
people with diabetes
Estimated cost of
diabetes
Estimated diabetes
prevalence increase
(%)
Estimated cost increase
(%)

2010
9.3

2020
14.4

47,000

73,000

$254 million

$322 million

56% increase from 20102020
27% increase from 20102020

Central to the delivery of primary care is the family physician; who during the provision of care,
manages information from a multitude of sources, integrates it into a system of biomedical
knowledge, and decides in cooperation with patients on a therapeutic course of action. (Figure 2).
Historically this has been accomplished with paper-based systems due to their ease of use, low
cost and widespread acceptance. The challenge with a paper-based office is that data are stored
in a passive format which prevents the automatic triggering of clinical decision support tools and
impedes decision-making. This process becomes significantly more involved when the family
physician is managing a chronic disease condition such as diabetes which has a high prevalence,
is frequently associated with comorbid conditions, requires multiple medications, involves
monitoring several biochemical markers, and intersects with multiple different providers. All of
these factors make diabetes an opportune disease state for the implementation of health
information technology (HIT).
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Figure 2: The Flow of information in primary care adapted from Ebell and Frame33
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HIT has been defined by the American Government Accountable Office (GAO) as “technology used
to collect, store, retrieve, and transfer clinical, administrative, and financial health information
electronically.” In practical terms this technology is used to provide documentation in medical
records, order labs and diagnostic imagery tests, generate prescriptions, schedule appointments
and follow-up, billing, messaging, providing patient resources and analysis and reporting. HIT
comprises a number of processes and systems with varying degrees of interoperability which
include Electronic Health Records (EHRs), Electronic Medical Records (EMRs), Personal Health
Records (PHRs), Computerized Physician Order Entry systems (CPOEs), Clinical Decision Support
systems (CDS), and electronic prescribing systems (e-prescribing).
Advances in HIT provide the clinician with expert, timely, and meaningful data about patients
and populations and have resulted in new opportunities for the design and delivery of healthcare.
HIT has been used to create diabetic registries which providers can use to perform clinical
audits.34 Patients can track their blood glucose and blood pressures electronically download
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those results into their computers and share them electronically with their primary care
provider.35 E-mail communications between patients, physicians and other care providers have
facilitated interactive feedback based upon uploaded results and patients have been provided
opportunity to view selected areas of their EMR all to produce better diabetic management.36 37

The principle difference between HIT systems is the level of information sharing and the
purported use for this information. An EHR is a secure and private lifetime record of health and
care history available electronically to authorized health care providers.38 In a Canadian context
the EHR is to be operated by provincial governments as a higher-level system that pulls
information from other systems such as EMR, PHR, and e-prescribing networks to allow for
monitoring of health outcomes and provide a pan Canadian patient record. In contrast an EMR is
a provider-centric tool that focuses on physician specific information. It is configured to reflect
the needs of the individual physician or a group of physicians who are providing direct patient
care and as such it will contain a record of every patient encounter.39 The EMR has a central role
in HIT as it is the principle system used by primary care providers and may interface directly
with the EHR providing population based information or indirectly through other systems such
as laboratory and diagnostic imagery ordering systems, pharmacy networks and provincial
billing systems. The configurability of the EMR allows for the sequencing of activities during
clinical encounters to improve the process by which care is delivered which is a perquisite to
improving patient outcomes in chronic disease states.
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1.3.2 Meaningful integration of electronic medical records into clinical workflow in the
management of diabetic patients
The extent to which HIT is incorporated in a meaningful way into the management of the adult
patient with type two diabetes can be conceptualizes in terms of both process measures and
outcome measures. A process measure indicate how care was delivered and includes any
diagnostic or therapeutic interventions while outcome measures are used to indicate the status
of a patient at the end of an episode of care.40 A literature review conducted in 2008 by Adaji et al
41

and published in Informatics in Primary Care identified 444 articles of which 29 were used in

the paper (25 that satisfied the inclusion and exclusion criteria and 4 which were drawn from the
references). Those authors found HIT lead to improved process measures such as increased
ordering of tests for biochemical markers,42 increased number of foot43 and eye examinations44,
increased immunizations45, and increased prescriptions for ACE inhibitors and Statins46. (Table
5)
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Table 5: Impact on Process Mearues on Diabetic Care (Adapted by Adajj)
Process Measure

Clinical Decision
Support
(access to expertise)

Clinical
Information
System

Delivery System
Design
(new design)

(access to data)

Foot check

Meigs (2003)

Statistically significant
improvement

Self
Management
support

(access to patient
tools)

East (2003)

Statistically significant
improvement

Montori (2002)

Statistically significant
improvement

Smith (1998)

Statistically significant
improvement

Eye check

Meigs (2003)

Montori (2002)

Branger (1999)

Non-statistically
significant
improvement

Statistically significant
improvement

Non-statistically
significant
improvement

Sequist (2005)
No improvement

Immunizations

East (2003)

Statistically significant
improvement

Montori (2002)

Statistically significant
improvement

Nutritional
advise and
change

Montori
(2002)

Glasgow (2003)

Smoking
cessation advise

Montori
(2002)

Glasgow
(2003)

Montori
(2002)

McKay (2001)

Physical activity
advise

Medications

Statistically significant
improvement

Statistically significant
improvement

Kim (2006)

Statistically significant
improvement

Sequist (2005)

Statistically significant
improvement

Statistically significant
improvement

Statistically significant
improvement
Non-statistically
significant
improvement

Kim (2006)

Statistically significant
improvement

No improvement

Outcome measures, specifically HbA1C and lipid levels, showed mixed results with some studies
showing no improvement47 while others showed statistically significant improvements.48 (Table
6).
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Table 6: Impact on Outcome Measures on Diabetic Care (Adapted by Adaj)
Outcome
Measure

Clinical Decision
Support

(Access to expertise)

Clinical
Information
System

Delivery
System Design

Kim (2006)

McMahon
(2005)

McMahon
(2005)

Branger (1999)

Glasgow (2003)

(New design)

(Access to data)

HbA1c

Smith (2004)

Statistically significant
improvement

Meigs (2003)
No statistically
significant
improvement

No statistically
significant
improvement

Self
Management
support

(Access to patient
tools)

Statistically
significant
improvement

Statistically
significant
improvement

O’Connor (2005)
No improvement

Statistically
significant
improvement

No statistically
significant
improvement

Levetan (2002)

Smith (2005)

Lee (2007)

Statistically significant
improvement

Statistically
significant
improvement

Statistically
significant
improvement

Bond (2007)
Statistically
significant
improvement

Kwon (2004)
Statistically
significant
improvement

Kim (2006)

No statistically
significant
improvement

Harno (2006)
Statistically
significant
improvement

Smith (2005)
Statistically
significant
improvement

LDL-cholesterol

Meigs (2003)

Statistically significant
improvement

O’Connor (2005)

McMahon
(2005)

No improvement

No improvement

McMahon
(2005)

No improvement

Glasgow (2003)
Statistically
significant
improvement

Harno (2006)
Statistically
significant
improvement

HDL-cholesterol

McMahon
(2005)

Statistically
significant
improvement

McMahon
(2005)

Statistically
significant
improvement

Glasgow (2003)
Bond (2007)
Statistically
significant
improvement

Kwon (2004)
Statistically
significant

19 | P a g e

improvement

TotalCholesterol

Glasgow (2003)
Statistically
significant
improvement

Lee (2007)
Statistically
significant
improvement

Bond (2007)
Statistically
significant
improvement

Harno (2006)
Statistically
significant
improvement

Triglycerides

McMahon
(2005)

Statistically
significant
improvement

McMahon
(2005)

Statistically
significant
improvement

Glasgow (2003)
Statistically
significant
improvement

Kwon (2004)
Statistically
significant
improvement

Harno (2006)
Statistically
significant
improvement

Blood pressure

Meigs (2003)

McMahon
(2005)

No improvement

Statistically
significant
improvement

McMahon
(2005)

Statistically
significant
improvement

Bond (2007)
Statistically
significant
improvement

Harno (2006)
Statistically
significant
improvement

Body weight

Blood glucose

Bond (2007)
Statistically
significant
improvement

Lee (2007)

Statistically significant
improvement

Kim (2006)

No statistically
significant
improvement

Lee (2007)
Statistically
significant
improvement

Kim (2006)

No statistically
significant
improvement
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The literature review by Adaji et al examined the impact from HIT systems which provided
clinical decision support in the form of access to expertise, clinical information systems which
provided patient data, delivery system designs which made changes to the means in which
diabetes care was delivered, and self-management support which empowered patients with the
information required to manage their diabetes. By the authors own admission their paper was
limited in that there was considerable variability in the methods used in the studies and the
papers considered were not scrutinized for methodological quality. That notwithstanding the
findings suggest that HIT can improve patient self-management, enhance the delivery of diabetes
care, and support clinical decision making with corresponding improvements in process and
outcome measures.

The meaningful integration of an EMR into the clinical workflow of the primary care provider is a
change management exercise and requires attention to the potential benefits and barriers of an
EMR implementation. (Table 7)
Table 7: Potential Benefits and Barriers of EMR use in Diabetes Management49
Potential Benefits
Increased quality of healthcare
Reduction in medication errors
Improvement in patient outcomes
Reduction in health disparities
Cost savings
Improved patient safety
Augmented chronic disease management

Potential Barriers
Initial cost
Physician resistance
Lack of funding
Fear of change
Privacy and security
Concerns of return on investment
Lack of vision

While cost, funding, and concerns over return on investment (which includes physician time) are
important to overcome, meaningful use of the EMR in diabetes management ultimately rests on
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the removal of physician resistance.50 Research has shown that physicians heavily weigh the
potential effects of EMR on routine workflow.51 (Table 8).
Table 8: Tasks Associated with Clinical Work-Flow52
Administrative Tasks
Scheduling appointments
Documenting patient information
Accessing patient records
Processing billing and claims
communication

Clinical Tasks
Medical treatment
Documentation of history
Examination and assessment of patient
Develop treatment plan
Patient education
Prescription of medication
Order entry
Arrange referrals and clinic follow-up

As noted by Leu et al., “Understanding the full clinical context for HIT to the level of the task,
resources, and workflow is a necessary prerequisite for successful adoption of HIT and
measurement of its diffusion.”53 This is a complex task and consequently the movement to
meaningful EMR implementation in the management of diabetes in the primary care setting has
not been realized. In general terms an EMR implementation can be conceptualized as five step
process requiring the physicians to, at each stage, identify and correct any issues that may
impede workflow process issues before, during and after the implementation. (Figure 3)54
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Figure 3: Phases of an EMR Implementation55

Phase 1

•Decision
•Process of identifying champions, gaining "buy-in", collecting information, understanding financial
issuesand analyzing benefits.

Phase 2

•Selection
•Process of understanding both the practice needs and the capabilities of the EMR systems under
consideration.

Phase 3

•Preimplementation
•Process of communicating with the involved parties to redesign workflows, establish a project plan
and arrange for training.

Phase 4

•Implementation
•Process of making and managing change which involves radid implementation and extensive
support

Phase 5

•Post implementation
•Process of continious updating, training, and evaluation

The post implementation phase is particularly important in relation to the meaningful use of the
EMR. It is a process of maturation, after the initial shift in work flow, where physicians use EMR
data in practice based population health management activities and/or use a specific bundle of
EMR functionalities for chronic disease management. Functionalities which include the creation
of patient registries for all diabetic patients, a systematic recall process for those patients,
diabetes focused visits, clinical flow sheets to display key outcome measures in a longitudinal
fashion to highlight trends, and links to expert management sites. According to the Alberta POSP
Benefits Survey conducted in 2012, 86% of physicians enrolled in the Alberta EMR program
reported that these functionalities improved their ability to manage patients with chronic
diseases.
1.4 Summary
The implementation of information technology enabled diabetes management has demonstrated
significant potential for improving the processes of care, preventing the development of diabetic
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complications, and generating cost savings to the health care system. It has been seen to improve
the synthesis of information, the delivery of knowledge, and the efficacy of communication;
thereby allowing for coordination of care across teams. The physicians, nurses, and administers
members of these teams hold different opinions about specific facilitators and barriers to
information technology and clinical guideline use and such disparaging perceptions can
undermine EMR initiatives. As such successful EMR implementation in guideline based chronic
disease management depends upon a variety of factors including the technology, training,
leadership, change management process, and the individual character of each ambulatory
practice environment. Sound change management processes must support both technical and
personal related organizational components. It is only through a multicomponent organizational
intervention with repeated interventions that an EMR in the primary care setting can significant
increase the percentage of type II diabetic patients achieving the recommended clinical
outcomes.

The use of an EMR in primary care practices, an environment characterized by short visits,
competing visit objectives, issues around the management of multiple patient morbidities and
medications, and patient and physician inertia related to the management of chronic disease, is
insufficient in and of itself for ensuring high-quality diabetes care. As such efforts to expand EMR
use in diabetic management should focus not only on improving technology but also on
developing methods for implementing and integrating this technology into practice reality. Steps
as simple as using the EMR to produce diabetes registries show significant potential benefit for
improving outcomes and reducing costs. Plan care, associated with improved performance and
metabolic outcomes in diabetes in the primary care setting, is easier to deliver to identifiable
patient populations. The EMR increase in the number of HbA1c and LDL tests ordered, but not
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linked to improve metabolic control, can be mitigated by simple flow charts graphically
representing trends in these values which support improved process of care by drawing the
attention of both physician and patient to values that are not at desired target . Thereby
facilitating decision-making in an individual patient’s care plan to alter medications, improve
clinical markers, and the quality of diabetic care.
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CHAPTER 2: Development of the Intervention
2.0 Overview of the chapter
The quality of outpatient diabetic care falls short of evidence-based care recommendations56, and
various strategies have been suggested to improve diabetic care. EMRs have been proposed as a
potentially effective information management tool for improving diabetes care57, and an Institute
of Medicine report has identified key features of EMRs that may lead to better care.58 Current
outpatient EMRs can be used to identify patients with diabetes, assess whether the patient is due
for recommended tests or screening procedures, and determine whether the patient has or has
not achieved evidence-based clinical goals for glycemic control, lipid control, and blood pressure
control.

Current diabetes care, in the primary care setting, is characterized by high rates of clinical inertia,
defined as a failure to intensify treatments in patients who have not achieved evidence-based
clinical goals. Rates of clinical inertia in diabetes visits exceed 50%59 and EMR technology seems
well-suited to reducing this problem thereby improving care.

2.1 Burden of Diabetes
The expenditures for the Newfoundland and Labrador Department of Health and Community
services for the 2010 fiscal year totaled $2.5 billion, which represented a $900 million dollar or
56% increase over the health costs for the fiscal year 2005.60 While some of the increase can be
attributed to the inflation relating to the cost of services and supplies, the bulk of the increase is a
function of an ageing population and an increasing prevalence of chronic disease. The province
has a significant issue with the prevalence of diabetes and the increasing health care costs
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relating to diabetes as evident from information provided by the National Diabetes Surveillance
System (NDSS) and the Canadian Diabetes Association (CDA).

2.1.1 Prevalence of diabetes in Newfoundland and Labrador
According to these organizations Newfoundland and Labrador has the highest rate of diabetes of
any jurisdiction in Canada at 9.3% of the population in 2010, which cost the province $254
million. The NDSS calculate the prevalence of the condition and estimated health care costs
based upon the Medical Care Plan (MCP) figures from fee-for-service claims and hospital files
which does not capture the information from the salaried primary care physicians who constitute
a third of the physician work force. Additionally the statistics for the aboriginal peoples, a
population known to have increased incidence of diabetes, are also not tracked. Subsequently
the prevalence and cost of diabetes are understated.

2.1.2 Prevalence of diabetes in Central Newfoundland
Within the Central regional integrated healthcare authority, which serves a total population
94,104 people, the prevalence of diabetes is listed at 11%.61 For the practices under study, which
provide primary health care services to 6475 patients, the number of patients listed as having
diabetes is 935 persons, which represents 14.4 % of the patient population.

2.2 Overview of EMR usage in Newfoundland and Labrador
The province of Newfoundland and Labrador is substantially behind other Canadian jurisdictions
in EMR use in part because it has no financial assistance or change management services for
physicians looking to implement EMRs into their practices. Provincial involvement in EMR
deployment has been limited to a pilot project completed in the Eastern Health Care Authority
almost a decade ago. The now defunct Office of Primary Health Care (OPHC) in partnership with
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four other organizations {the Newfoundland and Labrador Medical Association (NLMA), the
Memorial University of Newfoundland Family Practice Unit (MUNFPU), The Newfoundland Drive
Medical Clinic, and The Newfoundland and Labrador Centre for Health Information (NLCHI)}
collaborated on the production of this EMR demonstration project.

Funded by Canada Health Infoway and located within the Eastern Health Care Authority the
demonstration project consisted of a four site EMR implementation conducted in the three
academic family medicine clinics operated by MUN and one community clinic, which was also
involved in teaching. 62 The number of strategic partners in the demonstration project has not
been equaled in any subsequent EMR implementation and the legacy of this project had been to
share lessons learned with physicians interested in an EMR through a peer-to-peer network. The
success of that network was significantly limited by the absence of any financial support to EMR
pioneers in the province and the formal peer-to-peer network has closed due to a discontinuation
of its funding. The current number of EMR instillations around the province is a best guess and is
listed in the following table (Table 9).
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Table 9: EMR Installations in Newfoundland and Labrador
Western
RHA
Practicing
Physicians
Using EMR
Wolf

129

LabradorGrenfell
RHA
53

Central
RHA

Eastern RHA

Total

146

724

1052

6
0

0
0

14
0

44
27
(Demonstration
site)
16
1

64
27

Nightingale
Other

6
0

0
0

14
0

34
1

2.3 Selection deployment and maturity of the EMR in Central Newfoundland
In July 2008 six family physicians from three separate clinics relocated their practices to a newly
renovated facility complete with the largest privately funded electronic medical record
implementation in the province of Newfoundland and Labrador and located in the Central Health
Care Authority. The decision to transition from a paper-based system to an EMR was driven by
practical space and staffing considerations and was informed by the work done with the
provincial EMR demonstration project.
2.3.1 EMR Implementation
The Central Newfoundland EMR implementation was influenced by a number of factors
including: the character of the technology; nature of training required to deploy it; organizational
leadership; the change management process; and character of the practice environment.63 The
EMR demonstration project in Eastern Health was a larger practice setting implementation and
the difference in scale between it and the Central Health experience is both real and important.
The NLCHI was able to provide the Eastern Health demonstration project with a list of approved
vendors whose set technical, data, and messaging standards that were consistent with the
province’s HIT vision. The presence of dedicated IT personnel in the collaborating health care
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authority meant that an EMR solution with large servers installed in Eastern Health’s data centre
was possible. Involvement of multiple levels of leadership meant interfaces that accessed
provincial laboratory and diagnostic were quickly provided. The change management process
was overseen by a dedicated and trained team, the cost of the system was covered by an external
agency and the bulk of the clinical practices were remunerated in such a way that clinical
slowdowns had less of a finical impact. This is in contrast to the Central experience where the
absence of funding, meaningful engagement by agencies (other than NLCHI) and the clinical
volumes required a very different implementation strategy.

Generally, successful EMR implementation can be conceptualized as consisting of several phases:
decision; selection; pre-implementation; implementation and post-implementation. Central to
the implementation process is a structures approach to transitioning individuals and
organizations from a current state to a desired future state.64 Such a change management
strategy is subjected to less resistance in smaller organizations as there is a tendency within such
groups to seek steady state equilibrium.65 This was the principal advantage of the Central
Newfoundland EMR implementation. The driving vision behind the physician’s decision to
transition from paper charts to an EMR was to, improve patient care through more efficient
access to electronic records leading to improve office efficiencies, was developed in a very short
period of time. The close working relationships between the original group of physicians
shortened the process of identifying champions and gaining “buy in” while the previous work
done on the demonstration project meant that the collection of information on vendors, detailing
of financial issues, analysis of work flows and understanding the benefits were completed in
short order. Lessons learned by the NLCHI and communicated to the central physician group
lead to an appreciation of the need to hire a dedicated IT professional during the pre30 | P a g e

implementation phase. In addition to providing technical expertise this position also had the
responsibility to communicate with the physicians, office staff, and practice manager on the
redesign of the workflow and conduct of training. The implementation phase was largely
accomplished with the assistance of the vendor with ongoing support provided by the local
dedicated support person.

2.3.2 EMR Selection
At the end of this process the electronic medical record selected was the Nightingale EMR. This
product was chosen because of its perceived ease-of-use, ability to integrate clinical workflow,
cost savings resulting from decreased office staff, scalability, and overall affordability. The EMR is
an internet-based application service provider. The application architecture uses a 128 bit SSL
encryption and off-site data storage for the secure storage of patient information. The EMR uses
the JavaScript programming language with the Google Web toolkit, which is fairly standard for
Internet-based products. HTML 5/CSS3 is the markup language employed by the Nightingale
EMR to code for the formatting of the products layout.

2.3.3 EMR Maturity
The post implementation phase of the EMR in Central Newfoundland was largely limited to the
support of basic EMR usage focused on recordkeeping and clinical processes. This differed
considerably from the work that was done and continues to be done in jurisdiction such as
Alberta, British Columbia, Manitoba and Ontario. A white paper prepared by Canada’s Health
Informatics Association titled Canadian EMR Adoption and Maturity Model summarized the EMR
adoption models used in these four jurisdictions and produced a common Canadian EMR
Adoption and Maturity Model which can be used to track the physician use of EMR to impact
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clinical outcomes. The resultant common adoption model, suggested by the COACH’s Canadian
EMR adoption model, focused on three separate measures: functionality which includes the
usefulness of tools for a particular clinical environment; breadth representing number of users,
patients, and units, for a given product; and outcomes capturing improvements in patient health.
(Figure 4).

Functionality

(right, useful, appropriately rendered)

Figure 4: Common Adoption Model

Breadth

Extent of use

The white paper went on to build upon commonalities identified across the four jurisdictions to
provide a six level model of EMR adoption and maturity. This model portrays the advancement
of EMR maturity as physician’s progress through the respective levels (Table 10).
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Table 10: The Canadian EMR Adoption and Maturity Model
EMR Level
progression
Serial

EMR Adoption
Level
0 paper based

Description

Serial

1 basic electronic
record keeping

Serial

2 clinical
processes

Serial

3 Advanced disease
management

Iterative

4 Integrated care

Iterative

5 population impact

Paper is the dominant means of storing,
accessing, and exchanging information
EMR available with basic use for practice
management streamlining of foundational clinical
efficiency such as encounter documentation,
prescription creation and renewal, lab ordering
and scanning.
Establishes clinical processes with decisionmaking support at the individual patient level,
standardization of data coding and fully
structured workflow practices.
Enhanced delivery and support of care from
automated clinical workflow and process
including a focus on outcomes to manage
complications and on advanced tracking for
treatment adherence.
Supports adherence to optimal standards of care
across and between care teams planning and
reporting at the jurisdictional level through
integration and exchange of information at the
community and regional levels.
Profiles (based on risk or conditions) subpopulations; measures process and outcomes;
provides performance feedback; supports
regional health policy planning and reporting at
the jurisdictional level.

2.4 Tool development
The Nightingale electronic medical record does have a chronic disease management module
(CDM) that allows the product to be used to positively impact on entire populations of patients
facilitating advanced disease management. In some jurisdictions diabetes management is guided
by this CDM. Unfortunately the Nightingale implementation in the province of Newfoundland and
Labrador is substantially smaller than in other jurisdictions and in the absence of a coordinated
provincial EMR strategy the CDM functionality has not been engaged. As a result advanced
disease management using this electronic medical record had to employ existing features
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contained within the system to better organize the process of delivering diabetic care and
attempt to improve outcome measures. A survey of the EMR usage by the seven physicians being
studied indicated that they had some experience with the use of templates, premade laboratory
requisitions, prepared consultations, flow sheets, and patient alerts. Subsequently each one of
these functionalities was incorporated into the diabetic patient management tool, which
constituted the intervention in this study, and was designed to improve the process of delivering
diabetic care.

At the beginning of the study all of the patients with a diagnosis of diabetes identified by the ICD9 code 0250 had a flowchart added to their cumulative patient profile. The purpose of the
flowchart was to collect information from the diabetic clinical encounters and present that
information in a meaningful way to allow the physician to track individual patient’s HbA1c, LDL,
and blood pressure values. The tool was developed so that the physicians began their clinical
encounters in the usual manner. Once they opened a clinical encounter within the EMR they had
opportunity to click on a profile button which allowed them to load a prepared diabetic visits
note that automatically imported the diagnosis, prepared consultation letters, and clinical plan
notes. During the clinical encounter the physicians had opportunity to use a template of care that
guided the encounter and documented lab values, clinical examination, and education provided
in a number of searchable fields that allowed for the tracking of care provided and populated the
diabetic flow sheet.
2.5 Deployment of the IT solution
Upon completion of the configuration of all of the advanced EMR features to be used in the
processes of delivering diabetic care in this study was completed, a six-month beta-test was
conducted. During this period the diabetes management tool was used not by the IT personnel
34 | P a g e

who configured it but rather a clinician providing care to diabetic patients. Based upon the
feedback some minor changes were made to the layout but no substantial changes to the tool
were required. A seven page full-color double-sided professionally printed and bound “how to”
manual was produced detailing an 11 point process to use all of the features of the study
intervention (appendix 1). Each of the participating physicians was provided a copy of this
documentation during a one hour one-on-one educational process with a dedicated and
knowledgeable IT professional. Each physician was also made aware during these educational
sessions that at any time should they have any questions on how to use the tool that the IT
support personnel would be available to answer these questions. One month after the initial
education session each physician was approached by the IT support personnel and offered an
additional educational session.

2.6 Summary of the intervention
The intervention was characterized by the implementation of an advanced disease management
tool to transform the provider’s approach to managing diabetic patients in the family practice
clinic setting. The EMR was customized to: identify all patients with diabetes; provide structured
diabetic visit notes; prepared consultation letters; standardized laboratory requisitions; and
populate diabetic flow sheets. The flow sheets were a key component to the intervention as they
had been shown, in the past, to improve adherence to guidelines when it comes to assessing and
treating diabetes.
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CHAPTER 3: Evaluation of the Intervention
3.1 Introduction
This study was designed to determine whether the use of advanced features of an electronic
medical record in a primary care setting improved the process of delivering diabetic care
(frequency of visits, frequency of tests ordered, and documentation of critical results) and also
produced improvements in diabetic outcome measures (HbA1c, low-density lipoprotein, and
blood pressure values) in adult type two diabetic patients.

3.2 Setting
The study was conducted in primary care clinics that had established electronic medical records.
The clinics were community-based and contained only family physicians with no on-site allied
healthcare providers (regional diabetic clinics were available on a referral basis) and were
teaching sites affiliated with the family medicine program of Memorial University of
Newfoundland. Both of the EMR clinics were relatively small, with a stable staff of 3 to 4
physicians and were leaders in the province of Newfoundland and Labrador in the adoption and
use of electronic medical records. The community in which the clinics were embedded was
classified as rural in nature and demographically similar to many such centres within the
province. The EMR in the study was an Internet-based application service provider (ASP)
developed by Nightingale Informatics Corporation. The software itself is housed on a server
located in Markham Ontario, and backed up on a server located in Calgary Alberta, and the clinic
computers, which store no patient information, communicate with the servers over high-speed
Internet. The Nightingale Corporation provided regular updates to the electronic medical record
and on-site technical support was available in both the study clinics. The cost for the EMRs were
born by the individual physicians who, in addition to an initial purchasing and startup fee, paid
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monthly for continued access to the EMR. The EMR clinics also participated in other diabetesrelated care improvement activities through their involvement with the Canadian Primary Care
Sentinel and Surveillance network. This network, discussed elsewhere, provided information in
the form of a report card to each clinician about the quality of the diabetic care that they were
providing to their patients. Figure 5shows the timelines for the stages of EMR implementation
just described.

Figure 5: Timeline for the Central EMR
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The clinics involved in the study were a relatively new entity, beginning in July 2008 when the
physicians involved, transferred their practices from four separate offices into a new facility
complete with the largest privately funded electronic medical record implementation in the
province of Newfoundland and Labrador. The paper charts from the previous clinics were
initially made available to the physicians for six-month period while they transitioned fully to the
electronic medical record at which point the charts were then stored off-site. In 2012 the original
clinic expanded to the point where was necessarily to open up a second clinic. Physicians
typically consulted the EMR on a computer monitor located in each clinical examination room
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with each patient visit. The EMR is used to generate the clinical encounter note in the SOAP
format, order and manage pharmaceuticals, order and manage laboratory and diagnostic imaging
requests, and to generate consultations. Due to challenges between the clinics and the Regional
Integrated Healthcare Authority laboratory interface could not be established with the hospitalbased meditec system and as a result the physicians involved in the studies have had to manage
laboratory results outside of the electronic medical record. The advanced EMR features used
during the diabetic study included a diabetic template, premade laboratory requisitions,
prepared consultations, flow sheets, and patient alerts.

3.3 Selection of Participants
To evaluate the impact of the advanced EMR features on the process and outcomes of diabetic
care, the study focused on all adults with an established diagnosis of diabetes. The potential pool
of participants was drawn from all of those patients having been identified in the EMR, by
provider, as having diabetes mellitus with an ICD-9 code of 250. Each physician's roster of
diabetic patients was then reviewed with duplicate entries deleted to generate a list of possible
patient participants that was then subject to a further evaluation. The electronic medical record
of every patient rostered to the participating physicians, was reviewed to determine if they truly
were a type II diabetic over 18 years of age who attended the clinic regularly. The ICD-9 250 code
was routinely used by the participating physicians to identify those individuals who may possibly
have diabetes and subsequently required further investigations, or those patients who had
impaired fasting glucose or impaired glucose tolerance and required additional management
with regards to cardiovascular risk factors, and also used to capture those individuals who
experienced gestational diabetes. Subsequently it was required to review each patient record
looking at the cumulative patient profile (CPP), medication list for diabetes specific drugs, clinical
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notes for descriptions of diabetes, and laboratory requisitions or consultation notes, to determine
if the patient was an actual type II diabetic or file or fell into one of the other categories. This
methodology for the identification of diabetic patients was previously evaluated with an
estimated sensitivity of 0.91 and a specificity of 0.99 with a positive predictive value of 0.94.66

A total of 935 patients out of a total patient population of 6475 were identified with the ICD-9
code of 250 and 625 of these were excluded as either being non-diabetic, having type I diabetes
or gestational diabetes, or having not been see during the study or having died during the study
period. As a result a total of 310 patients were included in the study.

3.4 Dependent variables
The two types of dependent variables measured included the process of the delivery of diabetic
care and diabetic outcomes. The first type was process of care which was measured by the
proportion of patients with the recommended number of tests performed in the year. The
second type was the outcome of glycemic control as measured by HbA1C and lipid control (LDL)
in addition to BP control. These were subsequently compared to the targets identified within the
diabetes literature. Validity of the outcomes was enhanced by the following; all of the laboratory
tests performed during the study were performed at a single accredited clinical chemistry
laboratory managed and operated by a regional integrated healthcare authority.
The laboratory received its certificate of accreditation from the Institute for Quality Management
and Healthcare based upon an assessment conducted from 12 February 2010 until 12 March
2010 and this ISO 15189 Plus accreditation was valid for the entire study period. The LDL was
measured using a LDLD reagent in conjunction with SYNCHRON LX systems, UniCel DxC 600/800
systems, and SYNCHRON systems LDLD calibrator, to provide a direct qualitative determination
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of low-density lipoprotein cholesterol in human serum. The HbA1c was calculated using a Tosoh
Automated Glycohemoglobin Analyzers, which used a high-performance liquid chromatography
assay to provide a qualitative measure of the percentage of HbA1c in whole blood specimens.

3.5 Independent Variables
There was one independent variable of interest in this study: the extent to which the physicians
used the advanced diabetic patient management features of the EMR. This was measured by
reviewing every clinical encounter for those patients identified as having diabetes during the
study period to determine the number of diabetic visits in which the prepared diabetic care
template was used. This was dichotomized to the patients for whom the template was used at
least once versus not used ever.

3.6 Covariates
The covariates within the study include the patient's age and sex and these were obtained from
the demographic component of the electronic medical record for each patient.

3.7 Plan of Analysis
The analysis was designed to test two hypotheses: (1) use of the tool is associated with the
proportion of patients with the recommended number of tests performed in the year, and (2) use
of the tool is associated with the change in values of HbA1c, LDL, and BP over time. Analysis
conducted compared the two groups of patients at baseline and provides information about; Sex,
baseline HbA1c, baseline LDL, baseline systolic blood pressure, baseline diastolic blood pressure,
and number of visits during study period. Chi-squared was used to test for statistical significance.
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To control for potential confounders (age, sex, number of visits) logistic regression was
conducted for seven outcomes. Three process outcomes (HbA1c, LDL, and BP measured
according to guidelines) and four physiological outcomes (HbA1c, LDL, systolic BP and diastolic
BP achieved recommended targets). With an additional controlled variable being the baseline of
the relevant outcome.
Logistic regression was conducted for each of the seven outcomes. For each of the three process
outcomes (whether HbA1c, LDL, and BP was measured according to guidelines) the independent
variables were Group (tool vs no tool), Age, Sex, and Number of Visits (More than 3 visits vs 3 or
less).

For the target achievement outcomes (whether HbA1c, LDL, systolic BP and diastolic BP achieved
recommended targets) the independent variables were Group (tool vs no tool), Age, Sex, Number
of Visits (tool vs no tool), and the baseline level of HbA1c, LDL, or Blood Pressure, depending on
the dependent variable.

3.8 Results
The purpose of this research project was to determine if the advanced features of an electronic
medical record improve the processes by which primary care physicians delivered diabetic care
in such a way as to improve clinical outcomes. The results are represented in the following tables.
Table 11 contains a listing of the baseline characteristics and comparison variables between the
groups of the patients under study. The two groups are seen to be similar at baseline except for
age and systolic blood pressure. The mean age of the intervention group was four years older
than the comparison group and the comparison group had more people with systolic blood
pressure at target. These variables and others were controlled for using multivariate analysis.
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Table 11: Baseline Characteristics and Other Group Comparison Variables
Variable

Mean Age(Years)

Total Population
of Diabetic
Patients

Patients for Whom the
Template was Used as
least Once.

Patients for Whom
the Template was
Never Used

P Value*

N= 310

N=108

N=202

(Template used
vs Template not
used)

65.1 (SD: 11.5)

67.9 (SD: 10.1)

63.6 (SD: 11.9)

0.001

0.963

#(SD)
Sex

Male

157(50.6%)

54 (50%)

103 (51%)

#(%)

Female

153 (49.4%)

54 (50%)

99 (49%)

Baseline A1c at Target

Yes

121 (39%)

37 (34.3%)

84 (43.5%)

#(%)

No

180(58.1%)

71 (65.7%)

109 (56.5%)

Missing

9 (2.9%)

0

9

Baseline LDL at Target

Yes

155 (50%)

65 (62.5%)

90 (53.6%)

#(%)

No

117 (37.7%)

39 (37.5%)

78 (46.4%)

Missing

38 (12.3%)

4

34

Yes

138 (44.5%)

42 (42.9%)

96 (60%)

No

120 (38.7%)

56 (57.1%)

64 (40%)

Missing

52 (16.8%)

10

42

Yes

200 (64.5%)

76 (77.6%)

124 (77.5%)

No

58 (18.7%)

22 (22.4%)

36 (22.5%)

Missing

52 (16.8%)

10

42

More Than 3

112 (36.1%)

33 (30.6%)

79 (39.7%)

3 or less

195 (62.9%)

75 (69.4%)

120 (60.3%)

Missing

3 (1%)

0

3

Baseline Systolic BP at
Target
# (%)
Baseline Diastolic BP
at Target
# (%)
Number of Visits
during study period

0.147

0.187

0.011

0.999

0.143

* Based on available (non-missing) data, p value calculated using chi-squared test.
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Table 12 is a comparison of both the processes of delivering diabetic care and the outcomes of
that care between the patients who had the template used and those patients who did not have
the tool used during their clinical encounters. From this table some differences in the process of
delivering care can be seen. Although there were no differences in the two groups in terms of the
measurement of HbA1c there were some differences in the frequency of the measurement of LDL
and blood pressure. Patients in whom the tool were used during at least one encounter however
or 1.18 times more likely to have had their LDL measured and 1.9 times more likely to have their
blood pressure measured that than in those patients in whom the tool was never used. This table
also shows that there is no significance difference in the in the proportions of people at target for
HbA1c, LDL, or blood pressure at the end of the study.

There was no relationship between the Group (Template vs no template) and the Outcome for
Measurement of HbA1c, Proportion of patient with A1c at target, Proportion of patients with
systolic BP at target at end of study, or the Proportion of patients with diastolic BP at target at
end of study.

However, the tool (Template use during a clinical encounter) was associated with an increased
the likelihood that LDL would be measured, that Blood pressure would be measured, and
increased the proportion of patients with LDL at target at the end of the study (although this
result was borderline significant at p=0.046).
(See Logistic Regression Tables in Appendix 2)
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Table 12: Comparison of Patient Outcomes Between Template Used and Template Not Used

Variable

HbA1c Measured
according to
Guidelines

Yes

Patients for Whom
the Tool was Used
at least Once.

Patients for
Whom the Tool
was Never Used.

N=108

N=202

108 (100%)

195 (96.5%)

Interpretation
P Value

0.101

#(%)

LDL Measure
According to
Guidelines

No

0 (0.0%)

7 (3.5%)

Yes

103 (95.4%)

164 (81.2%)
0.001

#(%)

Blood Pressure
Measured according
to Guidelines

No

5 (4.6%)

38 (18.8%)

Yes

95 (88.0%)

151 (74.8%)
0.010

#(%)

HbA1c at target at
end of study

No

13 (12.0%)

51 (25.2%)

Yes

41 (38.0%)

93 (47.7%)

Patients in whom the template
was used during at least one
encounter were no more likely to
have HbA1c measured than in
patients where the template was
never used.

Patients in whom the template
was used during at least one
encounter were 1.18 times more
likely to have LDL measured than
in patients where the template
was never used.
Patients in whom the template
was used during at least one
encounter were 1.9 times more
likely to have BP measured than
in patients where the template
was never used.

0.130

No difference between groups in
proportion of people with HbA1c
at target at end of study

0.071

No difference between groups in
proportion of people with LDL at
target at end of study

#(%)
No

LDL at target at end
of study

67 (62.0%)

102 (52.3%)

Missing

0

7

Yes

67 (65.0%)

87 (53.0%)

#(%)

Systolic BP at Target
at end of study
#(%)

Systolic BP at Target
at end of study
#(%)

No

36 (35.0%)

77 (47.0%)

Missing
Yes

5
43 (45.3%)

38
83 (55.0%)

No

52 (54.7%)

68 (45.0%)

Missing

13

51

Yes

70 (73.7%)

100 (66.2%)

0.177

0.275
No

25 (26.3%)

51 (33.8%)

No difference between groups in
proportion of people with
systolic BP at target at end of
study

No difference between groups in
proportion of people with
diastolic BP at target at end of
study

Missing
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CHAPTER 4: Discussion of all sections
4.1 Background
This discussion will cover the three main topics of this thesis: the literature; developing the
intervention; and the study. This discussion contains: a background on the thesis; highlights
of the literature in relation to the study; highlights of the literature on development of tools
compared to the tool studies; implications for practice; recommendations for future
research; and conclusions.
The literature suggests the implementation of information enabled diabetes management
has demonstrated the potential to improve the process of delivering care, preventing the
development of diabetic complications, and generate cost savings. The dynamic nature of
the primary care practice environment represents a significant challenge to realizing these
theoretical benefits when deploying EMRs in guideline based chronic disease management.
Successful interventions require considerable change management process sensitive to the
character of each ambulatory practice environment with an emphasis on planned care of the
diabetic patient and the use of simple flow charts to graphically represent trends in values
and to facilitate decision-making directed at improving clinical markers.

Newfoundland and Labrador is the province with the highest rate of diabetes in Canada with
9.4% of the population affected in 2010 and a cost of care of $254 million dollars annually.
The incidence of diabetes in the Central Regional Health Care Authority and the practices
under study were even greater at 11% and 14.4% respectively. Using an EMR to manage
this chronic disease occurs in the post-implementation phase of an EMR deployment when
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the clinicians are comfortable with the basic functionalities such as encounter
documentation, prescription creation and renewal, and ordering of lab and diagnostic
imagery tests. At this point EMR use has matured to the extent that clinical work flow and
process of delivering care can shift to use of templates, premade laboratory requisitions,
prepared consultations, flow sheets and patient alerts to manage diabetic care.

The tool under study was developed so that the physicians began each clinical encounter in
the usual manner, once they opened a diabetic patient’s chart they had opportunity to load a
prepared diabetic encounter which automatically imported a care plan complete with
diagnosis, prepared consultation letters and populated clinically meaningful values (HbA1c,
LDL, BP) into searchable fields. The tool was beta tested for a six month period and then
launched with a one hour individual instructional session given by a dedicated HIT educator
using a professionally produced instructional manual. Additional sessions were available to
each provider on request.

The research question was to determine if the advanced feature of the electronic medical
record improved the process of diabetic care in such a way as to improve clinical outcomes.
When physicians used the diabetic tool during at least one encounter patients were 1.18
times more likely to have their LDL measures and 1.9 times more likely to have their blood
pressure measured. Logistic regression analysis indicated that the intervention increased
the proportion of patients with LDL at target at the end of the study.
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4.2 Comparison of the Study Findings to the Literature
Of the physicians understudy 42% of them used the tool at least once, obsticles to use may
have been the perceived increase in time required to use the tool or the question of the need
for a tool to improve the management of diabetics in their individual practices. In 2008
Wyne et al showed technology enabled diabetes management to have significant potential to
improve the process of delivery of care to diabetic patients. The use of a diabetic register,
which identified the patients requiring focused care, was noted to be particularly important.
Similar findings were seen in our research, in diabetic patients for whom the tool was used
were 1.18 times more likely to have their LDL measured and 1.9 times more likely to have
their blood pressure taken. Increased numbers of LDL tests ordered do not necessarily lead
to improved metabolic control (O’Connor 2005) and the use of an EMR in primary care
practice is insufficient for ensuring high quality diabetic care (Crosson 2007). However in
this study the LDL targets were better met with the tool was used.

The use of chronic diabetes management tools within an EMR is variable. Implementation
depends upon a number of factors including a change management process, which requires
both sound technical and personal related organizational components (Lorenzi 2009) and a
synergy between multiple approaches to encourage adoption (Bowens 2010). Successful
use of a specialized EMR tool for the measurement of the diabetic patient requires a
combination of tailored office workflow process and adherence to diabetic guidelines and
only physicians who changed their workflow to include diabetes specific visits were able to
incorporate the EMR tool into their practice (Ciemins 2009). Demonstrating again those
efforts to expand EMR use should focus not only on improving technology but also on
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developing methods for implementation and integrating technology into practice reality.
The variability in the use of the tool in the study reported in this thesis created a naturally
occurring experiment and allowed the comparative study to be conducted.

4.3 How does the development of the tool under study compare to the tools cited in the
literature.
Electronic medical records, according to Love et al, have the potential to facilitate the design
of large cluster randomized trials (CRTs), which are a preferred design to test interventions
intended to change physician or patient behavior. In his research, the Diabetes
Improvement Group-Intervention Trial (Dig-IT), Love was able to identify and balance preassigned characteristics for 12 675 patients cared for by 147 physicians in 24 practices all
using the same EMR. This allowed him to determine the effect of experiential interventions
of either EMR facilitated disease management or patient empowerment with or without
disease management. They showed that rigorous CRT designs allowing for fair comparisons
are possible.

This study was not a CRT but rather a retrospective cohort study design to determine if the
advanced features of an EMR in primary care clinics could improve the process and
outcomes associated with diabetic care. That notwithstanding, the same approach was used
to compare patients between practices and as seen in Table 3.1 shows the two groups were
similar on some variables. Variables that were not similar between groups were controlled
in the analysis using logistic regression.
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The translate trial was a multi component organizational intervention conducted in a
primary care setting (Peterson 2008). The intervention targeted a number of the
components of the chronic disease care model including implementation of an electronic
diabetes registry; visit reminders and patient and physician specific alerts. The electronic
diabetes registry was either incorporated into an existing computer system or placed on a
new computer system and a site coordinator trained in its use. The coordinator facilitated
pre visit planning and provided patient and physician specific reminders for each diabetic
patient visit. The site coordinator notified patients of scheduled visits and contacted high
risk patients with an elevated HbA1c or SBP as well as providing monthly summaries of
operational activity and tracked clinical measures. This produced significant increases in
the percentage of type two diabetic patients achieving recommended outcomes.

The tool under study in this study involved the production of a diabetic registry that was
incorporated into an existing EMR system, which included visit reminders and physician
specific alerts. In the absence of a site coordinator, it was the responsibility of each
physician to identify high-risk patients and track clinical measures.

Research into typical use of EMR in primary care practices comparing 16 EMR using
practices to 26 non-EMR using practices in a group-randomized quality improvement trial
showed that non-EMR practices were more likely to meet the targeted outcomes for HBA1c,
LDL, and blood pressure (Crosson 2012). The authors of this study suggested that this
result might have stemmed from the EMR practices not investing enough in changes to work
process and conceptualization of how this technology can be used in improving chronic
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illness management. Given the population management functions in commercially available
EMR are poor and an optional component of meaningful use criteria67 this finding is not
surprising. As noted above the solution in part would be to assign a member of the health
care team to maintain disease registries.

The change management process with the launch of the EMR in the clinics under study was
dedicated to basic electronic record keeping, billing processes and clinical workflow only in
so far as it pertains to scheduling of appointments. The study tool represented the first
attempt at advanced disease management with a focus on process and outcomes.

A five year longitudinal study of 122 adult type II diabetic patients involving EMR and nonEMR clinics showed EMR use lead to an increased number of HbA1c and LDL tests being
ordered but no improvement in metabolic outcomes (O’Connor 2005). It was thought EMR
use would assist in overcoming clinical inertia, defined as a failure to intensify treatment in
patients who have not achieved evidence based clinical goals, which has been cited as being
as high as 50%. The data suggested that in spite of the increased technical sophistication of
EMRs the link between processes of care and outcomes of care was tenuous; the level of
HbA1c and not the frequency of ordering the tests is what predict the risk of complications
and increased health costs.

The practice tools studied in this thesis research demonstrated similar findings with a
difference in the frequency of LDL and BP measurements but no appreciable improvement
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in the proportion of people at target for HbA1c or blood pressure. However, it did find an
increase in one clinical outcome, better LDL control.

A pre/post-intervention cohort analysis of 495 type two diabetic patients followed for six
years showed an increased adherence to ADA guidelines (Ciemins 2009). This study
consisted of two intervention phases; a “Low dose” period of targeted education to patients
and providers followed by a “high dose” diabetes management implementation phase. The
“high dose” intervention period was characterized by implementing an integrated EHR that
changed the clinic’s approach to managing complex chronic conditions. A diabetic registry
was constructed; point of care provider alerts and a diabetic management module was
designed, electronic forms for documentation created and patient and provider report cards
generated. At the study’s end patients were 3.5-6 times more likely to have been screened
for diabetic complications, 11 times more likely to have had tests ordered, and 2-3 times
more likely to have HbA1c, LDL, and BP controlled.

The absence of “high dose” diabetic management implementation phase with physician and
patient report cards meant that in practices considered in this author’s study that only three
of the seven physicians used the tool for their diabetic clinical encounters. These were part
of the four-physician group practicing in the clinic where this author was located.

4.4 Strengths and limitations
A randomized clinical trial would have been preferred over a retrospective cohort study but
was not possible in this real world setting. The physician’s choice on whether or not to use
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the tool limits this to an observational study preventing controlling for all confounders; such
as method of physician remuneration and patients geographical factors. The design did
however allow for controlling for patient age, sex, and number of visits.

4.5 Implications for practice
The Canadian EMR adoption model advances that improvement in patient outcomes,
measured in terms of reduced morbidity and mortality, follow naturally as a result of
improvement in care processes. The advanced EMR features used during the diabetic study
were designed to improve care processes using a visit template, prepared laboratory
requisitions, flow sheets (populated when laboratory values were entered into a defined
field), and patient alerts. Each one of these functionalities individually represented a feature
of the Nightingale EMR that each of the participating physicians was familiar with. However
this is the first time that all of those tools had been combined in the delivery of Clinical
Practice Guideline informed care. As such the intervention may have been daunting to some
of the clinicians and physician attitudes including skepticism about implementing GPGs into
their practice may also have been a factor on the EMR advanced features use.

The change management during the post implementation phase of the EMR in Central
Newfoundland was focused on the support of basic EMR usage and as such it rates at EMR
adoption level one on the six point Canadian EMR Adoption and Maturity Model. The
advanced EMR functionalities under study-represented maturity levels two and three
attempting to structure workflow for diabetic patients, standardize data, and focusing on
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meaningful clinical outcomes. As such it may have exceeded the sophistication of EMR use
by some of the providers.

The successful use of advanced EMR features, in guideline based chronic disease
management, requires understandable user-friendly technology, expert training, and a solid
change management process. The change management processes must support all aspects of
change both technical and personal. The intervention did not have a method beyond
education to support the physicians in making the changes required for the use of the
advanced diabetic management tool under study. The clinic with a 75% use of the
intervention did have an informal champion in that the author was imbedded in that clinic.
The individual character of each ambulatory practice may have also impacted on the tools
use, as the physicians with the higher percentage of diabetic patients in their practices were
more likely to use the tool.

It may be reasonable to conceptualize the treatment of diabetic patients in EMR clinics in
terms of process of care delivery and clinically significant outcome measures, and that this
treatment be delivered in a serial and progressive manner. With the identification of a
diabetic patient the clinician uses the basic recordkeeping functions of the EMR to document
clinical encounters, order required labs and medications and identify the patient to a
diabetic registry. The diabetic registry is constructed in such a way as to book follow up
appointments for diabetic specific visits, risk stratify patients based upon clinical outcome
measures. Clinical encounter templates then shift the process of care to clinical processes,
such as, starting and titrating metformin to as close to UKPDS 38 levels as the patient will
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tolerate and then shift pharmacological management to LDL and blood pressure control.
The final stage in EMR use would be a shift to advanced disease management where patients
not achieving clinical outcomes are identified for more intensive interventions and those at
targets have their care shifted to the management of the complications of diabetes.
4.6 Recommendations for future research
In the absence of significant incentives and disincentives to promote the meaningful use of
electronic medical records in smaller jurisdictions such as Newfoundland and Labrador,
research into the characteristics of physicians and practices that would lend themselves to
the use of advanced EMR functionality would be of merit. Audit tools to help these individual
clinicians identify areas of their practices that would benefit from advanced EMR
functionality would personalize such interventions. Research also conducted to identify the
optimal number of advanced features that can be used by a clinician during any one clinical
encounter would also be of particular value.

4.7 Conclusions
Electronic medical records are physician centric computer-based tools containing patient
demographics, medical and drug history, as well as diagnostic and laboratory information
presented in a manner that may or may not promote chronic disease management. They
have been described as being transformative in nature, with the potential to fundamentally
change the work, productivity, and processes of delivering care in community-based
practices. Chronic disease in general, and diabetes in particular present an ideal
opportunity for health information technology to demonstrate its ability to improve the
provision of chronic disease management in primary care medicine. Successful EMR
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implementation in guideline based chronic disease management is multifactorial and
requires consideration of the technology itself, training of physicians, leadership in clinical
excellence, and the individual character of each ambulatory practice environment. A solid
change management process that an EMR in the primary care setting can achieve the
maturity necessary to significantly increase the percentage of type II diabetic patients
achieving the recommended clinical outcomes only through the introduction of a
multicomponent intervention.

Maturity emerges in EMR use is an emergent property from the three separate domains of
functionality, breadth, and outcomes. A survey of the EMR usage by the seven physicians
being studied indicated that they had experience with the functionalities used in the design
of the advanced diabetic patient management tool, subsequently each one of these
functionalities was incorporated into the intervention in this study designed to improve the
process of delivering diabetic care. The breath of the study included seven physicians caring
for three hundred and ten patients who met the study inclusion criteria, with three of those
clinicians using the advanced diabetic management tool to care for a total 108 patients.
Those patients experienced an improvement in the process of delivering diabetic care being
1.18 times more likely to have had their LDL measured and 1.9 times more likely to have
their blood pressure measured during the clinical encounters. In terms of improvement in
outcome measures, using logistic regression, there was increase in the proportion of
patients with LDL at target at the end of the study.
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The meaningful use of EMRs in primary care, is possible through a process of maturity by
design; an individualized approach looking at the needs of a given physician(s) and their
practice(s) will be most likely to aid EMRs in achieving their potential. The technology
needs to support care by automation of clinical processes and work flow behind the
computer screen in such a way as to not disrupt or significantly change the patient physician
interaction and focus both of these individuals on managing meaningful clinical outcomes
personalized to each patient.
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Appendices

Appendix 1: Diabetes Study How--‐To
Current patients who have had a Diabetes Miletus (ICD 0250) diagnosis will have had the
Flowchart added to their CPP. All that needs to happen now is loading the Templates and
Profiles when the patient is in for the follow- up appointments.
To add the Diabetes Study and flowchart for newly diagnosed patients and send them for their
first diabetic panel:
1. Start the Encounter as usual.
2. Click on the “Profile” button at the top left of the Encounter.

3. In the Webpage Dialog window that opens, change the Master Profiles For: to Dr. John
Campbell.

4. In the profiles list, click the box at the right of the Diabetes Study I – Visit I (or whichever
visit this is) profile to put a checkmark in it and then click on the LOAD button at the top
left of the page. This will load the profile and automatically input the Diagnosis,
Consultations, Labs and Plan Notes into the Encounter.

5. Next, click on the LOAD TEMPLATE button at the top left of the page.

6. In the Webpage Dialog window that opens: (a.) change the View: drop down from
Provider Templates to Enterprise Templates (b.) click on the checkbox next to *Diabetes
Study to put a check mark in it (c.) then click the LOAD button.

a.

c.

b

(d.) The template will load and allow entry of data.

1. Fill in all the applicable sections, scroll down or tab into the check and text boxes. When
finished, click on the “SAVE” button to save the template into the Encounter. Whatever
is filled in will be placed into the Encounter.

2. There are three Consults associated with the first Diabetic session. One for Fundoscopic
exam, one for Diabetes Education and one for Diabetes Nutritional Education. You must
open each one and assign the Consultant and adjust the preset text to reflect your
current patient.
3. There is a Laboratory Requisition associated with this session, and all that is required is
asign and print.

4. The Plan Notes are filled in generically, so you need to adjust the text to reflect the
current status of your patient.

5. Once everything has been properly filled in, printed, signed and given to the patient,
close the encounter in your preferred way.

6. The data will be collected by the Flowsheet created for this template. In
order to activate the flowchart open the patient's CPP and click on the
Flowsheet link:
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There are no problem list items in the patient's cumulative profile.
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There are currently no active medications for this patient.

Loc]l.
J:ogout
D

Injections

I

[]

LIt

7. With the Flowsheet section heading highlighted in blue click on the Add button that will be in the
menu at the top left:
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The re are no consultations in the patient's cumulative profile.
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Past Medical History:
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FlowSheets
There are no flow sheets in tl1e patient's cumulative patient profile.
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8. a.) Choose the * Diabetes Study by clicking the check box and then the b.) Add button at
the top left:

b.)

a.)

9. The Flowsheet will open a window and collect the data that it is set to collect. Once it
has completed collection, you may review the data by a.) sliding the slide bar down.
When finished, click on the b.) Save button at the bottom of the window:

a.)

b.)

10. Once saved, the options at the bottom change to Print, Save or Close. Choose
whichever, but when done, choose the Close which will take you back to the CPP and
will show the Flowsheet active in the patient’s CPP.

11. All that is required now is to book the follow-up appointments. When the patient next
comes in, load the next Template and Profile, and fill in the data. The Flowsheet will
automatically update the data it is supposed to collect.
The End

Appendix 2: Logistic Regression Tables
a. Dependent Variable: Whether A1c Was Measured according to Guidelines
Variables in the Equation
95% C.I.for OR
Beta

S.E.

Template Used*

17.944

Age

Wald

df

Sig.

OR

Lower

Upper

3810.495 .000

1

.996

62096798.597 .000

.

-.026

.036

.511

1

.475

.974

.907

1.046

Sex

-.890

.852

1.090

1

.296

.411

.077

2.182

Number of Visits

-.236

.813

.084

1

.772

.790

.160

3.887

Constant

5.641

2.616

4.649

1

.031

281.715

* There is a nul value in the table making measurement of Odd Ratio (OR) erroneous.
b. Dependent Variable: Whether LDL was Measured According to Guidelines
Variables in the Equation
95% C.I.for OR
Beta

S.E.

Wald

df

Sig.

OR

Lower

Upper

Template Used

1.555

.501

9.650

1

.002

4.736

1.775

12.636

Age

.005

.015

.094

1

.760

1.005

.976

1.034

Sex

.726

.349

4.321

1

.038

2.066

1.042

4.095

Number of Visits

-.534

.352

2.299

1

.129

.586

.294

1.169

Constant

1.053

1.016

1.075

1

.300

2.867

c. Dependent Variable: Whether BP was Measured According to Guidelines
Variables in the Equation
95% C.I.for OR
B

S.E.

Wald

df

Sig.

OR

Lower

Upper

Template Used

.792

.347

5.201

1

.023

2.207

1.118

4.357

Age

.025

.013

3.907

1

.048

1.025

1.000

1.051

Sex

-.629

.298

4.451

1

.035

.533

.297

.956

Number of Visits

.201

.313

.412

1

.521

1.223

.662

2.257

Constant

-.192

.856

.050

1

.823

.825

d. Dependent Variable: Whether HbA1c was at target at End of Study
Variables in the Equation
95% C.I.for OR
B
Step

1a

Template Used

S.E.

Wald

df

Sig.

OR

Lower

Upper

-.433

.350

1.532

1

.216

.649

.327

1.287

Age

-.026

.017

2.226

1

.136

.975

.942

1.008

Sex

-.303

.343

.783

1

.376

.738

.377

1.446

Number of Visits

-.821

.376

4.770

1

.029

.440

.211

.919

Baseline A1c

-2.663

.324

67.583

1

.000

.070

.037

.132

Constant

21.047

2.634

63.862

1

.000 1382631855.181

e. Dependent Variable: Whether LDL was at target at End of Study
Variables in the Equation
95% C.I.for EXP(B)
B

S.E.

Wald

Df

Sig.

Exp(B)

Lower

Upper

Template Used

.772

.387

3.981

1

.046

2.165

1.014

4.623

Age

-.017

.017

.971

1

.324

.983

.951

1.017

Sex

.555

.375

2.188

1

.139

1.742

.835

3.633

Number of Visits

.434

.388

1.253

1

.263

1.544

.722

3.301

Baseline LDL

3.526

.382

85.229

1

.000

33.986

16.077

71.846

Constant

-1.240

1.141

1.180

1

.277

.289

f. Dependent Variable: Whether Systolic BP was at Target at End of Study
Variables in the Equation
95% C.I.for OR
B

S.E.

Wald

Df

Sig.

OR

Lower

Upper

Template Used

-.279

.291

.918

1

.338

.757

.428

1.338

Age

-.032

.014

5.016

1

.025

.969

.943

.996

Sex

.079

.284

.077

1

.782

1.082

.620

1.888

Number of Visits

-.365

.303

1.453

1

.228

.694

.384

1.257

Baseline systolic BP

-.032

.011

8.699

1

.003

.969

.949

.989

Constant

6.367

1.610

15.646

1

.000

582.279

g. Dependent Variable: Whether Diastolic BP was at Target at End of Study

Variables in the Equation
95% C.I.for OR
B

S.E.

Wald

df

Sig.

OR

Lower

Upper

Template Used

.309

.326

.900

1

.343

1.362

.719

2.580

Age

.011

.015

.553

1

.457

1.011

.982

1.040

Sex

.131

.309

.180

1

.671

1.140

.622

2.088

Number of Visits

-.209

.323

.419

1

.517

.811

.431

1.528

Baseline Diastolic BP

-.072

.021

12.157

1

.000

.931

.894

.969

Constant

5.200

1.910

7.412

1

.006

181.334

Appendix 3: Characteristics of Physicians
a. Physicians using tool
Sex
Male
Female
Female

Method of Remuneration
Fee for service
Salary
Fee for service

Graduation Date
2004
2004
2001

Method of remuneration
Fee for service
Fee for service
Salary
Fee for service

Graduation Date
2003
2010
2010
2003

b. Physicians not using tool
Sex
Male
Male
Female
Female
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Regional Medical Advisor Paramedicine CNRHC (2015-Present)
Newfoundland and Labrador College of Physicians and Surgeons Board Member
(2010-Present)
Member of Laboratory Interface Working Group EHR Project NLCHI (2010-Present)
Member of Pharmacy Governance Advisory Board NLCHI (2010-Present)
Member CPHSC (2010-Present)
Member primary care research network (Sept 2009-Present)
Canadian Association of Emergency Physicians (2004-Present)
Canadian Medical Association (1998-Present)
Newfoundland and Labrador Medical Association (1998-Present)
Past:
President Medical Staff CRNHC (2009- 2010)
Peer to Peer Network NLCHI (2008-2009)
Secretary Medical Staff CRNHC (2008 – 2009)
Co-Chair Quality Initiatives Emergency Medicine Central West Health Care Board
(2006-2013)
Membership Advisory Committee National Chapter CFPC (2007- 2009)
Member at Large Provincial Chapter CFPC (2006-2009)
Palliative Care Committee (2005-2010)
Chair of the Section of Residents for CFPC (2003-2004)
Administrative Resident Family Medicine Program (2003-2004)
Editorial Advisory Board for Canadian Family Physician (2002-2004)

LEISURE ACTIVITIES
The preparation and cooking of fine foods
Applied automotive sciences in the restoration of a 1980 Camero

VOLUNTEER EXPERIENCE
Responsible sexuality project Organized project, revised manual and conducted
training. (1999 and 2000)
Palliative Care volunteers
Victoria Hospice, Victoria, BC (December 1997May 1998)

